Latest Earnings Analysis
-
Banner (BANR) Q1 2024: Core Deposits Climb to 89%, Buffering Margin Compression Cycle
April 18, 2024 · BANR
-
Brandywine Realty Trust (BDN) Q1 2024: $400M Bond Pushes Debt Maturity to 2027, Leasing Pipeline Climbs 14%
April 18, 2024 · BDN
-
Apogee (APOG) Q4 2024: Glass Margin Doubles to 19.7% as Portfolio Shift Drives Profit Resilience
April 18, 2024 · APOG
-
Ally Financial (ALLY) Q1 2024: Auto Originations Hit $9.8B, NIM Expansion Set for Q2
April 18, 2024 · ALLY
-
Alaska Air Group (ALK) Q1 2024: Premium Revenue Up 11% as Core Profitability Surges Past Pre-Grounding Expectations
April 18, 2024 · ALK
-
BMI Q1 2024: Utility Water Sales Surge 29%, AMI Penetration Drives Margin Expansion
April 18, 2024 · BMI
-
America Movil (AMX) Q1 2024: Broadband Adds 562K, Fiber Penetration Hits 80% as Fixed Growth Outpaces Pay TV Decline
April 17, 2024 · AMX
-
BEAM (BEEM) Q4 2023: Revenue Triples, Margin Leverage Unlocks $4M Cost Downshift
April 17, 2024 · BEEM
-
Alcoa (AA) Q1 2024: Illumina Deal Unlocks $12M Synergy, Raw Material Savings to Surpass $310M Target
April 17, 2024 · AA
-
Abbott (ABT) Q1 2024: Medical Devices Surge 14%, Propelling Guidance Raise and Margin Expansion
April 17, 2024 · ABT
-
BankUnited (BKU) Q1 2024: Non-Broker Deposits Surge $644M, Funding Mix Inflection Drives Margin Stability
April 17, 2024 · BKU
-
Bank of America (BAC) Q1 2024: Sales & Trading Revenue Hits $5.2B as Deposit Growth Defies QT
April 16, 2024 · BAC
-
BYRN Q1 2024: DTC Sales Surge 98%, ROAS Hits 6.5x as Production Ramps to 18,000 Units
April 14, 2024 · BYRN
-
Citi (C) Q1 2024: $1.5B Cost Saves Unlocked as 7,000 Roles Cut, Resetting Operating Model
April 12, 2024 · C
-
Bank7Corp (BSVN) Q1 2024: NIM Holds at 4.58% as Asset Quality and Capital Discipline Anchor Strategy
April 12, 2024 · BSVN
-
BlackRock (BLK) Q1 2024: ETF Net Inflows Hit $67B, Powering Structural Growth Narrative
April 12, 2024 · BLK
-
Applied Digital (APLD) Q3 2024: 400MW Hyperscaler LOI Signals Multi-Billion Dollar Data Center Pivot
April 11, 2024 · APLD
-
Aehr (AEHR) Q3 2024: WaferPak Share Hits 63% as Segment Diversification Offsets Silicon Carbide Softness
April 09, 2024 · AEHR
-
Abivax (ABVX) Q4 2023: €500M Capital Raise Extends Runway to 2025 Data Readout
April 08, 2024 · ABVX
-
AngioDynamics (ANGO) Q3 2024: MedTech Revenue Climbs 13% as Portfolio Streamlines for Margin Upside
April 04, 2024 · ANGO
-
Conagra Brands (CAG) Q3 2024: Frozen Volume Swing Narrows 7 Points as Margin Focus Holds
April 04, 2024 · CAG
-
BlackBerry (BB) Q4 2024: QNX Royalty Backlog Jumps 27% as IoT Momentum Counters Cyber Uncertainty
April 03, 2024 · BB
-
Acuity Brands (AYI) Q2 2024: ISG Grows 17% as Margin Structure Strengthens
April 03, 2024 · AYI
-
ASTS Q4 2023: Operating Expenses Set to Drop 22% as Block 1 Nears Launch
April 01, 2024 · ASTS
-
Burning Rock (BNR) Q4 2023: Pharma Segment Grows 59% as Cost Cuts Drive Path to Profitability
March 29, 2024 · BNR
-
Better Home & Finance (BETR) Q4 2023: Expenses Down 71% as New Commission Model Targets Conversion Gap
March 28, 2024 · BETR
-
ATAT Q4 2023: Retail Revenue Jumps 283%, Cementing Second Growth Engine
March 28, 2024 · ATAT
-
China Automotive Systems (CAAS) Q4 2023: EPS Sales Jump 24.6% as Product Mix Drives Margin Upside
March 28, 2024 · CAAS
-
Ascent (ACNT) Q4 2023: $55M Tubular Sale Resets Balance Sheet, Shifts Focus to Specialty Chemicals Margin Recovery
March 28, 2024 · ACNT
-
Appleomics (APLM) Q4 2023: Cash Burn Extends Runway Through Q1 2025 as Vibratinib Data Drives Regulatory Focus
March 28, 2024 · APLM
-
BOSC (BOSC) Q4 2023: Robotics Division Turns Profitable, Sets Up for Double-Digit Growth
March 28, 2024 · BOSC
-
Achieve Life Sciences (ACHV) Q4 2023: $124M Financing Secured to Accelerate Cytisinicline NDA Path
March 28, 2024 · ACHV
-
Altimmune (ALT) Q4 2023: 74% Fat Loss Ratio, Differentiates Pembidutide in Obesity and MASH Pipeline
March 27, 2024 · ALT
-
Braze (BRZE) Q4 2024: $639M RPO Signals Enterprise Upsell Momentum and Expanding Multi-Year Commitments
March 27, 2024 · BRZE
-
AACG Q4 2023: Net Loss Narrows 29.7% as Student Enrollment Rebounds
March 26, 2024 · AACG
-
Acumen (ABOS) Q4 2023: $306M Cash Extends Runway, Phase 2 Altitude-AD Launches on Biomarker Momentum
March 26, 2024 · ABOS
-
Amco Pittsburgh (AP) Q4 2023: Air & Liquid Sales Jump 35% Amid $40.9M Asbestos Charge Reset
March 26, 2024 · AP
-
ATOS (ATOS) Q4 2023: Tech Foundations Margin Jumps 210bps as Portfolio Shift Accelerates
March 26, 2024 · ATOS
-
BuzzFeed (BZFD) Q4 2023: Complex Sale Lifts Gross Margin by 400bps, Refocuses on High-Margin Digital Core
March 25, 2024 · BZFD
-
Bakkt (BKKT) Q4 2023: Crypto Trading Volume Surges 206% in March, Platform Scale Inflection Ahead
March 25, 2024 · BKKT
-
Astronova (ALOT) Q4 2024: T&M Segment Jumps 10% as Margin Expansion Anchors FY25 Targets
March 22, 2024 · ALOT
-
American Healthcare REIT (AHR) Q4 2023: Trilogy NOI Margin Climbs to 16.7% as Senior Housing Outpaces Medical Office
March 22, 2024 · AHR
-
AAR (AIR) Q3 2024: Commercial Distribution Soars 27% as Parts Mix Drives Margin Expansion
March 21, 2024 · AIR
-
Accenture (ACN) Q2 2024: $21.6B Bookings Underscore Demand Shift to Large Transformations
March 21, 2024 · ACN
-
Baozun (BZUN) Q4 2023: Gross Margin Jumps 13 Points as Brand Management Drives Turnaround
March 21, 2024 · BZUN
-
ASM Q4 2023: Cash Margin Rises to 29% as La Preciosa Permitting Sets 2024 Growth Catalyst
March 21, 2024 · ASM
-
Academy Sports & Outdoors (ASO) Q4 2023: New Store Plan Expands to 180 as Margins Hold Above 34%
March 21, 2024 · ASO
-
Amprius Technologies (AMPX) Q4 2023: Customer Count Climbs to 41 as Capacity Constraints Shape 2024 Trajectory
March 21, 2024 · AMPX
-
Alvotech (ALVO) Q4 2023: 3-4x Revenue Surge Forecast on Global Biosimilar Launches and Milestones
March 21, 2024 · ALVO
-
Corporación América Airports (CAAP) Q4 2023: Revenue Per Passenger Jumps 40% Versus 2019 as Network Recovery Broadens
March 21, 2024 · CAAP